Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

6 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Fallopian Tube Cancer NCT00262847 Follow-Up - GOG-0218 Follow-Up Form - 2303387v3.0 - GOG-0218 Follow-Up Form

- 09.01.15 - 1 Formular, 10 Itemgruppen, 38 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, VITAL STATUS, DISEASE FOLLOW-UP STATUS, NOTICE OF PROGRESSION/RECURRENCE, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS, FOOTER MODULE
GOG-0218 Follow-Up Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F0E07E6F-7EF7-42B7-E034-0003BA3F9857

Ovarian Cancer NCT00993655 Follow-Up - NCIC OV 21 Follow-Up Report Form - 2874229v1.0 - NCIC OV 21 Follow-Up Report Form

- 09.01.15 - 1 Formular, 14 Itemgruppen, 60 Datenelemente, 1 Sprache
Itemgruppen: Patient Information, TIMING OF REPORT, PHYSICAL EXAM, RESPONSE ASSESSMENT - QUESTION 2, TARGET LESIONS, NON-TARGET LESIONS DURING TREATMENT, NEW LESIONS, RADIOLOGY, CA 125 - TABLE, ADVERSE EVENTS / INTERCURRENT ILLNESS, ANTI-CANCER TREATMENT, QUALITY OF LIFE QUESTIONNAIRE, Comments, Contact Information
NCIC OV 21 Follow-Up Report Form Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=69B8C40D-B83D-E610-E040-BB89AD43211A

Fallopian Tube Cancer NCT01081262 Follow-Up - GOG-0241 Follow-Up Form (Q) - 3126299v1.0 - GOG-0241 Follow-Up Form (Q)

- 09.01.15 - 1 Formular, 8 Itemgruppen, 32 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS
GOG-0241 Follow-Up Form (Q) Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D161DC6-F374-44EE-E040-BB89AD431853

Fallopian Tube Cancer NCT00108745 Follow-Up - Follow-Up Form, GOG-0212, Form Q - 2296326v3.0 - Follow-Up Form, GOG-0212, Form Q

- 09.01.15 - 1 Formular, 10 Itemgruppen, 38 Datenelemente, 1 Sprache
Itemgruppen: HEADER MODULE, VITAL STATUS, DISEASE FOLLOW-UP STATUS, NOTICE OF PROGRESSION/RECURRENCE, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS, FOOTER MODULE
Follow-Up Form, GOG-0212, Form Q Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E7488E3D-0DD6-4AC5-E034-0003BA3F9857

Ovarian Cancer NCT00993655 Follow-Up - NCIC OV 21 Short Follow-Up Report Form - 2874233v1.0 - NCIC OV 21 Short Follow-Up Report Form

- 09.01.15 - 1 Formular, 4 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Patient Information, PHYSICAL EXAM, Comments, Contact Information
NCIC OV 21 Short Follow-Up Report Form Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=69B8C40D-B845-E610-E040-BB89AD43211A

GYNECOLOGIC ONCOLOGY GROUP Follow-Up Form - FORM Q NCT00565851

- 03.07.15 - 1 Formular, 8 Itemgruppen, 34 Datenelemente, 1 Sprache
Itemgruppen: Header module, VITAL STATUS, NOTICE OF PROGRESSION, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, Comments
GYNECOLOGIC ONCOLOGY GROUP Follow-Up Form - FORM Q NCT00565851 Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA625200-CCA6-1B50-E034-0003BA12F5E7

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video